Clinical trials
Tooth Discoloration trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
85 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2013 | 2 |
| 2014 | 3 |
| 2015 | 9 |
| 2016 | 2 |
| 2017 | 7 |
| 2018 | 5 |
| 2019 | 7 |
| 2021 | 6 |
| 2022 | 10 |
| 2023 | 4 |
| 2024 | 12 |
| 2025 | 5 |
| 2026 | 9 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 51 |
| Unknown status | 18 |
| Not yet recruiting | 6 |
| Active, not recruiting | 4 |
| Recruiting | 4 |
| Enrolling by invitation | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cairo University | 17 |
| Tanta University | 4 |
| University of Chile | 4 |
| Boka LLC | 3 |
| Home Skinovations Ltd. | 3 |
| Aristotle University Of Thessaloniki | 2 |
| Cardenal Herrera University | 2 |
| Dow University of Health Sciences | 2 |
| Ege University | 2 |
| Federal University of Pelotas | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Tooth Discoloration | 85 |
| Dentin Sensitivity | 12 |
| Gingivitis | 5 |
| Hypersensitivity | 5 |
| Tooth Fractures | 4 |
| Periodontitis | 3 |
| Dental Plaque | 2 |
| Diastema | 2 |
| Periodontal Diseases | 2 |
| Stomatognathic Diseases | 2 |
Trials
Showing 51 to 75 of 85. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.